Alex Zapesochny

Alex Zapesochny serves as CEO at Clerio Vision, Inc.. Clerio Vision, Inc. operates in the medical devices sector with approximately 40.0 employees. The company is headquartered in Rochester, New York. To date, Clerio Vision, Inc. has raised 40151384.0 in total funding, with the most recent round being Venture (Round not Specified).

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Route 53 Outlook WordPress.org Mobile Friendly Google Font API Android Python Remote AI

laser opthalmic medical device contact lenses intraocular lenses myopia control medical equipment manufacturing laser vision correction presbyopia femtosecond lasers liric technology multifocal contact lenses therapeutic lenses visual acuity non-invasive laser surgery refractive index change presbyopia correction myopia progression optical patterns lens design advanced lens technology clinical studies vision correction optometry ophthalmology vision sciences accurate prescriptions cataract surgery post-implant adjustments glare reduction eye care innovations vision health lens customization low vision sports vision optical engineering photonic innovation refractive error clinical trials management patent filed medical device development patient satisfaction side effects reduction visual experience enhancement customized optics monofocal lenses youth myopia optics & photonics visual problems advanced optics optometric advancements healthcare technology hospital & health care medical devices

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Alex Zapesochny in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Clerio Vision, Inc..

Alex Zapesochny's Position in the MessageCEO Database

• •Alex Zapesochny is 1 of 1 verified executive contact we track at Clerio Vision, Inc..
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •6,778 verified executive contacts in New York are in the database.
• •37 verified contacts work at medical devices companies in the 40.0 employee range (same size as Clerio Vision, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Alex Zapesochny directly?

Alex Zapesochny's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Clerio Vision, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Alex Zapesochny work for?

Alex Zapesochny is CEO at Clerio Vision, Inc., a company in the medical devices sector with 40.0 employees. The company is based in Rochester, New York.

Can I pitch or sell to Alex Zapesochny?

As CEO at Clerio Vision, Inc., Alex Zapesochny is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Alex Zapesochny directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Alex Zapesochny in?

Alex Zapesochny works in the medical devices industry as CEO at Clerio Vision, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Alex Zapesochny's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Alex Zapesochny's profile is kept up-to-date with the latest available information.

Last updated: June 24, 2026